Informações de Boston Scientific Corp | Histórico, dados financeiros e desempenho de mercado

Informações de Boston Scientific Corp Empresa

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. It also owns the transcarotid artery revascularization (TCAR) platform.

Informações da empresa

Código da empresaBSX

Nome da EmpresaBoston Scientific Corp

Data de listagemMay 19, 1992

Fundado em1979

CEOMr. Michael F. (Mike) Mahoney

Funcionários53000

Tipo de TítulosOrdinary Share

Fim do ano fiscalMay 19

Endereço300 Boston Scientific Way

CidadeMARLBOROUGH

Bolsa de ValoresNYSE Consolidated

PaísUnited States of America

Código postal01752-1234

Telefone15086834000

Sitehttps://www.bostonscientific.com/en-US/Home.html

Código da empresaBSX

Data de listagemMay 19, 1992

Fundado em1979

Executivos da Empresa

Nome

Nome/Posição

Posição

Ações Detidas

Variação

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.87M

-3.05%

Mr. Charles J. Dockendorff, CPA

Independent Director

62.90K

--

Mr. John E. Sununu

Independent Director

52.64K

--

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

41.02K

-10.53%

Ms. Ellen M. Zane

Independent Director

34.94K

--

Mr. David C. Habiger

Independent Director

3.55K

--

Mr. Yoshiaki Fujimori

Independent Director

2.90K

--

Ms. Miriam O' Sullivan

Chief Human Resource Officer, Senior Vice President

--

Mr. Edward J. Ludwig

Lead Independent Director

--

Mr. Scott Olson

Senior Vice President, President - Cardiac Rhythm Management and Diagnostics

--

Ver Mais

Nome

Nome/Posição

Posição

Ações Detidas

Variação

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.87M

-3.05%

Mr. Charles J. Dockendorff, CPA

Independent Director

62.90K

--

Mr. John E. Sununu

Independent Director

52.64K

--

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

41.02K

-10.53%

Ms. Ellen M. Zane

Independent Director

34.94K

--

Mr. David C. Habiger

Independent Director

3.55K

--

Detalhamento da Receita

Moeda: USDTempo de atualização: qua, 2 de abr

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Por EmpresaUSD

Nome

Receita

Proporção

Endoscopy

2.69B

16.04%

Interventional Cardiology Therapies

2.65B

15.79%

Peripheral Interventions

2.41B

14.39%

Cardiac Rhythm Management

2.28B

13.61%

Urology

2.20B

13.14%

Other

4.53B

27.03%

Por RegiãoUSD

Nome

Receita

Proporção

United States

10.21B

60.97%

EMEA (Europe, Middle East and Africa)

3.23B

19.28%

Asia Pacific

2.69B

16.04%

Latin America and Canada

624.00M

3.73%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Endoscopy

2.69B

16.04%

Interventional Cardiology Therapies

2.65B

15.79%

Peripheral Interventions

2.41B

14.39%

Cardiac Rhythm Management

2.28B

13.61%

Urology

2.20B

13.14%

Other

4.53B

27.03%

Acionista

Tempo de atualização: sex, 21 de fev

Estatísticas do Acionista

Tipo

Estatísticas do Acionista

Acionista

Proporção

The Vanguard Group, Inc.

8.94%

Fidelity Management & Research Company LLC

8.19%

BlackRock Institutional Trust Company, N.A.

5.19%

State Street Global Advisors (US)

4.32%

PRIMECAP Management Company

2.50%

Other

70.86%

Estatísticas do Acionista

Acionista

Proporção

The Vanguard Group, Inc.

8.94%

Fidelity Management & Research Company LLC

8.19%

BlackRock Institutional Trust Company, N.A.

5.19%

State Street Global Advisors (US)

4.32%

PRIMECAP Management Company

2.50%

Other

70.86%

Tipo

Acionista

Proporção

Investment Advisor

43.30%

Investment Advisor/Hedge Fund

37.30%

Hedge Fund

3.29%

Pension Fund

2.97%

Research Firm

2.45%

Bank and Trust

1.64%

Sovereign Wealth Fund

1.47%

Private Equity

0.21%

Insurance Company

0.21%

Other

7.16%

Instituição Participações

Tempo de atualização: dom, 19 de jan

Período do Relatório

Nº de instituições

Ações detidas

Proporção

Variação

2025Q1

2535

1.38B

93.49%

+4.22M

2024Q4

2559

1.38B

93.61%

+1.09M

2024Q3

2417

1.37B

92.76%

-24.32M

2024Q2

2341

1.37B

93.29%

-18.17M

2024Q1

2227

1.37B

93.23%

-40.14M

2023Q4

2171

1.39B

94.95%

-25.34M

2023Q3

2110

1.39B

95.17%

-6.29M

2023Q2

2081

1.38B

95.67%

-15.63M

2023Q1

2012

1.36B

94.85%

-23.81M

2022Q4

1993

1.36B

94.66%

-54.91M

Ver Mais

Atividade dos Acionistas

Nome

Ações detidas

Proporção

Variação

Chg %

Data

The Vanguard Group, Inc.

132.25M

8.94%

+1.62M

+1.24%

Dec 31, 2024

Fidelity Management & Research Company LLC

121.20M

8.19%

-2.05M

-1.66%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

76.72M

5.19%

+7.50M

+10.84%

Dec 31, 2024

State Street Global Advisors (US)

63.96M

4.32%

+1.12M

+1.78%

Dec 31, 2024

PRIMECAP Management Company

36.93M

2.5%

-896.83K

-2.37%

Dec 31, 2024

Wellington Management Company, LLP

36.17M

2.45%

+3.34M

+10.19%

Dec 31, 2024

Geode Capital Management, L.L.C.

30.63M

2.07%

+1.04M

+3.52%

Dec 31, 2024

Capital World Investors

27.90M

1.89%

+6.22M

+28.67%

Dec 31, 2024

The Bollard Group, LLC

20.73M

1.4%

-510.32K

-2.40%

Dec 31, 2024

BlackRock Investment Management (UK) Ltd.

20.37M

1.38%

+757.90K

+3.86%

Dec 31, 2024

Ver Mais

ETFs Relacionados

Tempo de atualização: qua, 2 de abr

Nome

Proporção

iShares U.S. Medical Devices ETF

12.01%

Goldman Sachs Future Health Care Equity ETF

8.56%

NYLI Healthy Hearts ETF

5.62%

iShares Health Innovation Active ETF

5.12%

JPMorgan Healthcare Leaders ETF

4.25%

Global X Aging Population ETF

4.17%

Hennessy Stance ESG ETF

3.4%

FT Raymond James Multicap Growth Equity ETF

2.84%

Tema Cardiovascular and Metabolic ETF

2.83%

Health Care Select Sector SPDR Fund

2.82%

Ver Mais

iShares U.S. Medical Devices ETF

Proporção12.01%

Goldman Sachs Future Health Care Equity ETF

Proporção8.56%

NYLI Healthy Hearts ETF

Proporção5.62%

iShares Health Innovation Active ETF

Proporção5.12%

JPMorgan Healthcare Leaders ETF

Proporção4.25%

Global X Aging Population ETF

Proporção4.17%

Hennessy Stance ESG ETF

Proporção3.4%

FT Raymond James Multicap Growth Equity ETF

Proporção2.84%

Tema Cardiovascular and Metabolic ETF

Proporção2.83%

Health Care Select Sector SPDR Fund

Proporção2.82%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro das ações

Data de pagamento

Data de ex-dividendo

Sem dados

Desdobramento de Ações

Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados

Boston Scientific Corp

89.700USD

Boston Scientific Corp

89.700

Visão Geral

Empresa